Deep-learning-designed enhancers drive target-tissue reporter activity in mouse embryos
Researchers trained convolutional neural networks on E11.5 mouse heart, limb and midbrain chromatin-accessibility data, then fine-tuned the models using validated human and mouse enhancers and used model-guided sequence optimization to design 15 synthetic enhancers. In vivo transgenic reporter assays found all 15 reproducibly active in their intended tissue. Four of five heart designs and four of five CNS designs were exclusive to the target tissue; all five limb designs were strongly active in limb and had weaker activity in other TWIST1-expressing mesenchymal tissues.
Technology: Convolutional neural networks for sequence-to-accessibility and sequence-to-activity prediction, transfer learning, and Ledidi gradient-based sequence design
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Researchers trained convolutional neural networks on E11.5 mouse heart, limb and midbrain chromatin-accessibility data, then fine-tuned the models using validated human and mouse enhancers and used model-guided sequence optimization to design 15 synthetic enhancers.
- Still unknown: The functional test was a transgenic reporter assay at embryonic day 11.5, not editing or activation of an endogenous native gene locus. Fifteen selected sequences were tested (five per target), so the reported all-positive result does not estimate success across every generated candidate. Some designs had weaker off-target activity, particularly in related mesenchymal tissues. These results do not establish therapeutic efficacy or safe gene therapy.
- AI role: Models learned tissue-specific chromatin-accessibility patterns from genome-wide ATAC-seq, then transfer learning adapted them to validated enhancer activity. The trained models guided de novo enhancer sequence edits; the authors selected 15 candidates for transgenic mouse-embryo reporter testing, where each showed reproducible activity in its intended target tissue.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13553301/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.